---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-126797"
form_type: "8-K"
ticker: "VYGR"
cik: "0001640266"
company_name: "Voyager Therapeutics, Inc."
filed_at: "2022-12-14T23:59:59+00:00"
generated_at: "2026-06-21T04:48:12.197325+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Voyager Therapeutics appoints Grace E. Colón, Ph.D. to board of directors, effective Jan 1, 2023

## Summary
- Grace E. Colón appointed as Class I director; term runs until 2025 annual meeting.
- Annual cash retainer of $40,000 for board service; $6,000 for Compensation Committee membership.
- Initial option grant of 44,000 shares vesting quarterly over four years; annual option of 22,000 shares thereafter.
- Dr. Colón also serves as Executive Chair of ProterixBio and director of CareDx; no family relationships with officers.

## SEC filing metadata
- accession: 0001104659-22-126797
- form_type: 8-K
- ticker: VYGR
- cik: 0001640266
- company_name: Voyager Therapeutics, Inc.
- filed_at: 2022-12-14T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1640266/000110465922126797/0001104659-22-126797-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1640266/000110465922126797/tm2232536d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-126797
- JSON: https://secwatch.observer/filing/0001104659-22-126797.json
- Plain text: https://secwatch.observer/filing/0001104659-22-126797.txt

## Key facts
- Executive change
  Grace E. Colón was appointed as director at Voyager Therapeutics, Inc..
  - Action: appointed
  - Role: director
  source text: appointed Grace E. Colón, Ph.D. as a director of the Company and as a member of the Compensation Committee of the Board, effective January 1, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1640266/000110465922126797/0001104659-22-126797-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.